Skip to main content

Table 1 Laboratory characteristics of the studied patients

From: Methyltransferase-like 3 gene (METTL3) expression and prognostic impact in acute myeloid leukemia patients

Variable

 

AML group (n = 40)

TLC

Median (IQR)

36.05 (2.5–70)

HGB

Mean ± SD

Range

7.37 (1.62)

3.3–10.4

PLT

Median (IQR)

22.5 (13.3–54.8)

BM blasts count

Mean ± SD

74.53(17. 76)

FAB classification

N

(%)

 M0–M1

3

7.5%

 M1–M2

19

47.5%

 M3

10

25.0%

 M4

6

15.0%

 M5

2

5.0%

Cytogenetic findings

t(8,21) (q22;q22)

2/19

5%

t(15;17) (q22;q21)

5/10

12.5%

Inv. 16/t(16;16) (p13;q22)

1/4

2.5%

11q23

0/1

0

t(9;22) (q34;q11)

0/7

0

  1. TLC total leucocyte count, HGB hemoglobin, PLTs platelets, BM bone marrow, FAB French–American–British classification, SD standard deviation, IQR interquartile range